Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Brian Lewis MD, MPH, FACP

Brian E. Lewis MD, MPH, FACP

Assistant Professor of Clinical Medicine, Department of Hematology and Medical Oncology, Tulane University School of Medicine, New Orleans, Louisiana

Biographical Sketch:

Dr. Brian Lewis is an Assistant Professor of Clinical Medicine in the Department of Hematology and Medical Oncology at Tulane University School of Medicine in New Orleans. He is also the Chair of the Fellowship Advancement Committee of the Hematology and Medical Oncology Fellowship Program at Tulane.

Following his graduation from George Mason University in Fairfax, Virginia, Dr. Lewis enrolled in the Tulane University School of Public Health and, upon completing his MPH degree, entered medical school at Tulane. He completed his medical degree and residency training in internal medicine at Tulane, where he also completed his fellowship in hematology and medical oncology.

Dr. Lewis is a member of several professional societies, including the American Society of Hematology and the American Society of Clinical Oncology. Dr. Lewis is a Fellow of the American College of Physicians.

Positions:
Assistant Professor of Clinical Medicine, Department of Hematology and Medical Oncology; Chair, Fellowship Advancement Committee, Hematology and Medical Oncology Fellowship Program, Tulane University School of Medicine

Degrees:
MPH: Tulane University School of Public Health, New Orleans, Louisiana
MD: Tulane University School of Medicine

Disclosures

Dr. Brian Lewis does not have any financial interests to disclose.

Recent Contributions to PracticeUpdate:

  1. 2019 Top Stories in Advanced Prostate Cancer: Cabazitaxel vs Abiraterone or Enzalutamide in Metastatic Prostate Cancer
  2. ESMO 2019: Recommendations From Dr. Brian Lewis
  3. Efficacy and Safety of Abiraterone Acetate Plus Prednisone vs Cabazitaxel as a Subsequent Treatment After First-Line Docetaxel in mCRPC
  4. Ultra-Hypofractionated vs Conventionally Fractionated Radiotherapy for Prostate Cancer
  5. PSA After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and EBRT
  6. ASCO 2019: Abstract Recommendations From Dr. Brian Lewis for Prostate Cancer
  7. Abiraterone Acetate Plus Prednisone in Newly Diagnosed High-Risk Metastatic Castration-Sensitive Prostate Cancer
  8. Patient-Reported Outcomes Following Enzalutamide or Placebo in Men With Nonmetastatic, Castration-Resistant Prostate Cancer
  9. Addition of Radium-223 to Abiraterone Acetate and Prednisone or Prednisolone in Patients With Castration-Resistant Prostate Cancer and Bone Metastases
  10. 2018 Top Stories in Oncology: Advanced Prostate Cancer

Most Read This Week

Recently Updated